ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    COG ACNS0821
Previous Study | Return to List | Next Study

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01217437
Recruitment Status : Active, not recruiting
First Posted : October 8, 2010
Last Update Posted : June 20, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 31, 2017
  Study Completion Date : No date given